Results for tag: "Trisenox"

Trisenox (arsenic trioxide) is a chemotherapy drug used to treat acute promyelocytic leukemia (APL). It is a type of antineoplastic agent, which works by inducing apoptosis (cell death) in cancer cells. Trisenox is administered intravenously and is usually given in combination with other drugs. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of APL in adults and children. The Trisenox market is composed of pharmaceutical companies that manufacture and distribute the drug. These companies are responsible for the research and development of the drug, as well as its marketing and sales. The market is highly competitive, with several companies vying for market share. Some of the companies in the Trisenox market include Cephalon, Inc., Teva Pharmaceuticals, and Sun Pharmaceutical Industries Ltd. Show Less Read more